BRCA1 and cancer: In this nested case-control study including 637 women developing TNBC and 511 developing HGSOC, white blood cell BRCA1 promoter methylation was associated with a significantly elevated risk of developing both cancer forms (hazard ratio for HGSOC of 1.93 and TNBC of 2.35).